Stanley Druckenmiller
GILD icon

Stanley Druckenmiller’s Gilead Sciences GILD Stock Holding History

Stanley Druckenmiller’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,023,345
Closed -$64M – 66
2018
Q4 		$64M Sell
1,023,345
-441,555
-30% -$30.9M 3.71% 10
2018
Q3 		$113M Buy
1,464,900
+259,600
+22% +$19.6M 5.38% 6
2018
Q2 		$85.4M Buy
+1,205,300
New +$85.1M 4.12% 7
2014
Q4 		– Sell
-217,500
Closed -$23.2M – 40
2014
Q3 		$23.2M Buy
+217,500
New +$21.3M 2.84% 10
2014
Q1 		– Sell
-610,700
Closed -$45.9M – 31
2013
Q4 		$45.9M Hold
610,700
– – 3.06% 9
2013
Q3 		$38.4M Hold
610,700
– – 4.54% 7
2013
Q2 		$31.3M Buy
+610,700
New +$31.8M 4.65% 8

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stanley Druckenmiller's GILD Position: Q1 2019 in Review

Stanley Druckenmiller sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 1,023,345 shares — an estimated $64M sold.

Stanley Druckenmiller first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $113M in Q3 2018. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Stanley Druckenmiller reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Stanley Druckenmiller sold 1,023,345 Gilead Sciences shares in Q1 2019, an estimated $64M.
  • Stanley Druckenmiller first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • Stanley Druckenmiller's Gilead Sciences position peaked at $113M in Q3 2018.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Duquesne Family Office's 13F filing for Q1 2019, filed 15 May 2019.